Madle S, Obe G
Hum Genet. 1980;56(1):7-20. doi: 10.1007/BF00281566.
The review discusses the variety of methods for activation of indirect mutagens/carcinogens and testing them in cell cultures, especially in mammalian cell cultures. After the necessity for including metabolizing components in mutagenicity tests has been pointed out, the enzymes that transform foreign compounds metabolically, and the factors influencing them, are described. In the main section the various methods of activating indirect mutagens/carcinogens are presented. The methods of including in vivo metabolism in mutagenicity tests are: Analysis of cells from organisms contaminated with a chemical (III.l.a); body fluid-mediated mutagenesis (III.l.b); host-mediated assay (III.l.c). The following activation systems are suitable for including in vitro metabolism of test compounds in mutagenicity tests: Liver and lung perfusion (III.2.a.alpha); organ slices and homogenates (III.2.a.beta); subcellular fractions (III.2.a.gamma); cultivated cells (cell-mediated mutagenesis) (III.2.b); nonenzymatic activation systems (III.2.c). Finally the main factors that influence the metabolism of test substances are summarized. Two factors illustrate the mutagenicity tests with regard to the metabolism of mammalian livers and the methods of performing mutagenicity tests in man.
本综述讨论了激活间接诱变剂/致癌物并在细胞培养物中,特别是在哺乳动物细胞培养物中对其进行测试的多种方法。在指出致突变性试验中纳入代谢成分的必要性之后,描述了对外源化合物进行代谢转化的酶及其影响因素。在主要部分介绍了激活间接诱变剂/致癌物的各种方法。在致突变性试验中纳入体内代谢的方法有:分析受化学物质污染的生物体的细胞(III.l.a);体液介导的诱变(III.l.b);宿主介导的测定(III.l.c)。以下激活系统适用于在致突变性试验中纳入受试化合物的体外代谢:肝脏和肺灌注(III.2.a.α);器官切片和匀浆(III.2.a.β);亚细胞组分(III.2.a.γ);培养细胞(细胞介导的诱变)(III.2.b);非酶激活系统(III.2.c)。最后总结了影响受试物质代谢的主要因素。有两个因素说明了关于哺乳动物肝脏代谢的致突变性试验以及在人体中进行致突变性试验的方法。